The Bioartificial Pancreas: Progress and Challenges Review

THE BIOARTIFICIAL PANCREAS 981
39. Toso C, Oberholzer J, Ceausoglu I, Ris F, Rochat B,
Rehor A, Bucher P, Wandrey C, Schuldt U, Belenger
J, Bosco D, Morel P, Hunkeler D: Intra-portal injection
of 400 microcapsules in a large animal model.
Transplant Int 2003;16:405–410.
40. Qian JH, Hashimoto T, Fujiwara H, Hamaoka T:
Studies on the induction of tolerance of alloantigens.
I. The abrogation of potentials for delayed-type-hypersensitivity
responses to alloantigens by portal venous
inoculations with allogeneic cells. J Immunol
1985;134:3656–3661.
41. Alejandro R, Mintz DH, Noel J, Latif Z, Koh N, Russell
E, Miller J: Islet cell transplantation in Type I
diabetes mellitus. Transplant Proc 1987;19:2359–
2361.
42. Brendel MD, Hering B, Schultz AO, Bretzel RG:
International Islet Transplant Registry. Newsletter
8. Giessen, Germany: Justus-Liebig-University of
Giessen, 1999.
43. Pfeiffer EF: Artificial pancreas, glucose sensors and
the impact upon diabetology. Int J Artif Organs
1993;16:636–644.
44. Pfeiffer EF, Kerner W, Beischer W: Substitution of
islet cell function by mechanical device: extracorporeal
artificial pancreas. Adv Exp Med Biol 1979;
119:501–508.
45. Kruse-Jarres JD, Braun G, Naegele R, Bresch M,
Lehmann U: Blood glucose monitoring and computer
regulation by means of an artificial endocrine
pancreas. Horm Metab Res Suppl 1979;8:42–45.
46. Kerner W, Beischer W, Herfarth C, Pfeiffer EF: Application
of an artificial endocrine pancreas in the
management of the diabetic surgical patient. Horm
Metab Res Suppl 1979;8:159–161.
47. Hunkeler D: Allo transplants xeno: as bioartificial organs
move to the clinic. Ann N Y Acad Sci 2001;944:
1–6.
48. Encapsulation & immunoprotective strategies of
islet cells. Diabetes Technol Ther 2002;4:361.
49. Prokop A: Bioartificial pancreas: materials, devices,
function and limitations. Diabetes Technol Ther
2001;3:431–449.
50. Chang TMS: Semipermeable microcapsules. Science
1964;146:524–525.
51. Sun AM, O’Shea GM, Goosen MF: Injectable microencapsulated
islet cells as bioartificial pancreas.
Appl Biochem Biotechnol 1984;10:87–99.
52. Wiegand F, Kroncke KD, Kolb-Bachofen V: Macrophage
generated nitric-oxide as cytptoxic factor in
destruction of alginate-encapsulated islets. Transplant
Proc 1993;56:1206–1212.
53. Soon-Shiong P, Otterlie M, Skjak-Braek G, Smidsrod
O, Heintz R, Lanza RP, Espevik T: An immunologic
basis for the fibrotic reaction to implanted microcapsules.
Transplant Proc 1991;23:758–759.
54. Strand BL, Ryan TL, In’t Veld P, Kulseng B, Rokstad
AM, Skjak-Brek G, Espevik T: Poly-L-lysine induces
fibrosis on alginate microcapsules via the induction
of cytokines. Cell Transplant 2001;10:263–275.
55. De Vos P, Wolters GHJ, Fritschy WM, Van Schilfgaarde
R: Obstacles in the application of microencapsulation
in islet transplantation. Int J Artif Organs
1993;16:205–212.
56. Goosen MFA: In: Lanza RR, Chick WL, eds. Immunoisolation
of Pancreatic Islets. Austin, TX: R.G.
Landes Co., 1994:21–44.
57. Soon-Shiong P, Feldman E, Nelson R, Heintz R, Yao
Q, Yao Z, Zheng T, Merideth N, Skjak-Braek G, Espevik
T, Smidsrod O, Sandford P: Long-term reversal
of diabetes by the injection of immunoprotected
islets. Proc Natl Acad Sci U S A 1993;90:5843–5847.
58. Lanza R, Langer R, Chick WL: Principles of Tissue
Engineering, 2 nd ed. Orlando, FL: Academic Press,
2000.
59. Colton CK, Avgoustiniatos ES: Bioengineering in development
of the hybrid artificial pancreas. J Biomech
Eng 1991;113:152–170.
60. Brissova M, Lacik I, Powers AC, Anilkumar AV,
Wang TG: Control and measurement of permeability
for design of microcapsule cell delivery system.
J Biomed Mater Res 1998;39:61–70.
61. Cole DR, Waterfall M, McIntyre M, Baird JD: Microencapsulated
islet grafts in the BB/E rat: a possible
role for cytokines in graft failure. Diabetologia
1992;35:231–237.
62. Fan MY, Lum Z, Levesque L, Tai IT, Sun AM: Reversal
of diabetes in BB rats by transplantation of encapsulated
rat islets. Diabetes 1990;39:519–522.
63. Iwata H, Takagi T, Kobayashi K, Oka T, Tsuki T, Ito
F: Strategy for developing microbeads applicable to
islet xenotransplantation into a spontaneous diabetic
NOD mice. J Biomed Mater Res 1994;28:1201–1207.
64. Lanza RR, Chick WL, eds.: Immunoisolation of Pancreatic
Islets. Austin, TX: R.G. Landes Co., 1994.
65. Lacik I, Brissova M, Anilkumar AV, Powers AC,
Wang TG: New capsule with tailored properties for
the encapsulation of living cells. J Biomed Mater Res
1998;39:52–60.
66. Lum ZP, Tai P, Krestow I, Tai T, Sun AM: Xenografts
of microencapsulated rat islets into diabetic mice.
Transplant Proc 1992;53:1180–1183.
67. Iwata H, Murakami Y, Ikada Y: Control of complement
activities for immunoisolation. Ann N Y Acad
Sci 1999;875:7–23.
68. Paul LC: Mechanism of humoral xenograft rejection.
In: Cooper DKC, Kemp E, Reemtsma K, White D,
eds. Xenotransplantation. Berlin: Springer-Verlag,
1991:47–67.
69. Auchincloss HJ, Moses R, Conti D, Sundt T, Smith
C, Sachs DH, Winn HJ: Rejection of transgenic skin
expressing a xeno-class I antigen is CD4-dependent
and CD8-independent. Transplant Proc 1990;22:
1059–1060.
70. Sayegh MH, Watschinger B, Carpenter CB: Mechanisms
of T cell recognition of alloantigen. The role
of peptides. Transplantation 1994;57:1295–1302.
71. Chen G, Hohmeier HE, Gasa R, Tran VV, Newgard
CB: Selection of insulinoma cell lines with resistance